| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Dec 20, 2024 | Prelude Therapeutics Inc | CFO | Buy | 91.3 | +25,000 | 1041.67% | ✗ | $22.6K |
| May 24, 2023 | May 25, 2023 | Prelude Therapeutics Inc | Chief Legal Officer, Corp Sec. | Buy | 91.3 | +2,400 | 100.00% | ✗ | $12.9K |